<code id='B3F598391A'></code><style id='B3F598391A'></style>
    • <acronym id='B3F598391A'></acronym>
      <center id='B3F598391A'><center id='B3F598391A'><tfoot id='B3F598391A'></tfoot></center><abbr id='B3F598391A'><dir id='B3F598391A'><tfoot id='B3F598391A'></tfoot><noframes id='B3F598391A'>

    • <optgroup id='B3F598391A'><strike id='B3F598391A'><sup id='B3F598391A'></sup></strike><code id='B3F598391A'></code></optgroup>
        1. <b id='B3F598391A'><label id='B3F598391A'><select id='B3F598391A'><dt id='B3F598391A'><span id='B3F598391A'></span></dt></select></label></b><u id='B3F598391A'></u>
          <i id='B3F598391A'><strike id='B3F598391A'><tt id='B3F598391A'><pre id='B3F598391A'></pre></tt></strike></i>

          leisure time

          leisure time

          author:explore    Page View:558
          Novo Nordisk Denmark
          LISELOTTE SABROE/AFP/Getty Images

          A pill being developed by Danish drugmaker Novo Nordisk may lead to greater weight loss than the obesity therapy Wegovy, the company reported Thursday, citing early data.

          In a Phase 1 trial, participants experienced an average of 13.1% weight loss after 12 weeks of taking the experimental oral medicine amycretin, according to data presented at an investor meeting. In comparison, in an earlier Phase 3 trial of the injectable drug Wegovy, people taking Wegovy lost about 6% of their body weight over the same time period.

          advertisement

          Novo Nordisk has been on a mission to capitalize on its success with Wegovy, which brought in $4.5 billion in sales last year. (The drug is also sold as a diabetes treatment under the name Ozempic. That version of the drug brought in another $14 billion in sales).

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          leisure time

          How to save PrEP access — and even expand it
          How to save PrEP access — and even expand it

          UndertheAffordableCareAct,healthinsurersarerequiredtocoverallcostsassociatedwithpreventivecare—inclu

          read more
          Pancreatic cancer early detection could be helped by AI
          Pancreatic cancer early detection could be helped by AI

          SuzanneKreiter/GlobestaffLimorAppelbaumhasseentoomanypatientswhosefirstsignofafatalillnesscametoolat

          read more
          The cancer drug shortage isn’t new — and neither are the solutions
          The cancer drug shortage isn’t new — and neither are the solutions

          PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

          read more

          Readout LOUD podcast: Live from STAT Breakthrough Summit West

          Onthisweek’s“ReadoutLOUD,”we’reliveinSanFranciscoatSTAT’sBreakthroughSummitWest.AIisabigthemethisyea